Search results
Pulse Biosciences pioneers in the research, design and production of our patented Nanosecond Pulsed Field Ablation ™ (nsPFA ™) technology for use in high impact areas of healthcare. We are currently focused on applying our proprietary CellFX ® nsPFA ™ technology within cardiology.
- Investors
The Investor Relations website contains information about...
- Code of Business Conduct and Ethics
Pulse Biosciences, Inc. (“Pulse”) is committed to...
- Press Releases
Pulse Biosciences Schedules First Quarter 2024 Financial...
- Investors
6 days ago · Pulse Biosciences, CellFX, Nano-Pulse Stimulation, NPS, nsPFA, CellFX nsPFA and the stylized logos are among the trademarks and/or registered trademarks of Pulse Biosciences, Inc. in the United...
6 days ago · Pulse Biosciences, Inc. (Nasdaq: PLSE) (the “Company” or “Pulse Biosciences”), a company leveraging its novel and proprietary CellFX® Nanosecond Pulse.
Dec 20, 2023 · Pulse Biosciences, CellFX, Nano-Pulse Stimulation, NPS, nsPFA, CellFX nsPFA and the stylized logos are among the trademarks and/or registered trademarks of Pulse Biosciences, Inc. in the...
Jan 2, 2024 · Pulse Biosciences, CellFX, Nano-Pulse Stimulation, NPS, nsPFA, CellFX nsPFA and the stylized logos are among the trademarks and/or registered trademarks of Pulse Biosciences, Inc. in...
About Pulse Biosciences® Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients. The Company’s proprietary CellFX® nsPFA™ technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue.
academic.oup.com has been visited by 10K+ users in the past month
JLB is the first fully Open Access, peer-reviewed legal journal. Discover the benefits of submitting to JLB.